718 Article(s)Download |
PMID | Title | Pub. Year | #Total Relationships |
201 | 22405646 | Synthesis and biological evaluation of novel bifendate derivatives bearing 6,7-dihydro-dibenzo[c,e]azepine scaffold as potent P-glycoprotein inhibitors. | 2012 May | 1 |
202 | 22411726 | Intestinal transport of pure diester-type alkaloids from an aconite extract across the Caco-2 cell monolayer model. | 2012 May | 1 |
203 | 22545578 | Up-regulation of P-glycoprotein is involved in the increased paclitaxel resistance in human esophageal cancer radioresistant cells. | 2012 Jul | 1 |
204 | 22584255 | Inhibition of P-glycoprotein leads to improved oral bioavailability of compound K, an anticancer metabolite of red ginseng extract produced by gut microflora. | 2012 Aug | 2 |
205 | 22588188 | No evidence for additional blood-brain barrier P-glycoprotein dysfunction in Alzheimer's disease patients with microbleeds. | 2012 Aug | 2 |
206 | 22734651 | Development of peptide-based reversing agents for p-glycoprotein-mediated resistance to carfilzomib. | 2012 Aug 6 | 1 |
207 | 22764578 | Blood-brain barrier in vitro models as tools in drug discovery: assessment of the transport ranking of antihistaminic drugs. | 2012 May | 3 |
208 | 22792804 | [Effect of Shaoyao Gancao Tang on function and expression of P-glycoprotein in Caco-2 cells]. | 2012 Apr | 4 |
209 | 23046348 | BBA, a derivative of 23-hydroxybetulinic acid, potently reverses ABCB1-mediated drug resistance in vitro and in vivo. | 2012 Nov 5 | 1 |
210 | 23072916 | Intestinal permeability of lamivudine (3TC) and two novel 3TC prodrugs. Experimental and theoretical analyses. | 2012 Dec 18 | 2 |
211 | 23134497 | P-glycoprotein imaging in temporal lobe epilepsy: in vivo PET experiments with the Pgp substrate [11C]-verapamil. | 2012 Nov | 3 |
212 | 23519262 | Absorption and interaction of the main constituents from the traditional Chinese drug pair Shaoyao-Gancao via a Caco-2 cell monolayer model. | 2012 Dec 13 | 3 |
213 | 20563580 | Effect of MDR modulators verapamil and promethazine on gene expression levels of MDR1 and MRP1 in doxorubicin-resistant MCF-7 cells. | 2011 Apr | 3 |
214 | 20824508 | Assessing p-glycoprotein (Pgp) activity in vivo utilizing 68Ga-Schiff base complexes. | 2011 Oct | 3 |
215 | 21062675 | Reversion of resistance to immunosuppressive agents in three patients with psoriatic arthritis by cyclosporine A: modulation of P-glycoprotein function. | 2011 Jan | 2 |
216 | 21128075 | Over-expression of MDR1 in amrubicinol-resistant lung cancer cells. | 2011 Sep | 1 |
217 | 21229388 | Influence of P-glycoprotein on embryotoxicity of the antifouling biocides to sea urchin (Strongylocentrotus intermedius). | 2011 Mar | 2 |
218 | 21289467 | Upregulation of P-glycoprotein activity in porcine oocytes and granulosa cells during in vitro maturation. | 2011 Jun | 2 |
219 | 21308736 | Euphorbia factor L1 reverses ABCB1-mediated multidrug resistance involving interaction with ABCB1 independent of ABCB1 downregualtion. | 2011 Apr | 1 |
220 | 21336515 | Assessment and modulation of phillyrin absorption by P-gp using Caco-2 cells and MDR1-MDCKII cells. | 2011 Mar | 1 |
221 | 21336967 | P-glycoprotein enhances radiation-induced apoptotic cell death through the regulation of miR-16 and Bcl-2 expressions in hepatocellular carcinoma cells. | 2011 May | 3 |
222 | 21371443 | A unique P-glycoprotein interacting agent displays anticancer activity against hepatocellular carcinoma through inhibition of GRP78 and mTOR pathways. | 2011 May 1 | 2 |
223 | 21439263 | On-line identification of P-glycoprotein substrates by monitoring of extracellular acidification and respiration rates in living cells. | 2011 Jul | 2 |
224 | 21440934 | The mechanism of enhancement on oral absorption of paclitaxel by N-octyl-O-sulfate chitosan micelles. | 2011 Jul | 1 |
225 | 21491921 | Liposome-encapsulated doxorubicin reverses drug resistance by inhibiting P-glycoprotein in human cancer cells. | 2011 Jun 6 | 1 |
226 | 21538216 | Resistance to the translation initiation inhibitor silvestrol is mediated by ABCB1/P-glycoprotein overexpression in acute lymphoblastic leukemia cells. | 2011 Sep | 1 |
227 | 21589945 | Exhaustive sampling of docking poses reveals binding hypotheses for propafenone type inhibitors of P-glycoprotein. | 2011 May | 1 |
228 | 21634011 | Identification of xanthones as selective killers of cancer cells overexpressing the ABC transporter MRP1. | 2011 Aug 1 | 1 |
229 | 21636258 | Regulation of endocytosis into human brain-microvascular endothelial cells by inhibition of efflux proteins. | 2011 Oct 1 | 2 |
230 | 21692796 | In vitro transport profile of carbamazepine, oxcarbazepine, eslicarbazepine acetate, and their active metabolites by human P-glycoprotein. | 2011 Oct | 1 |
231 | 21716273 | Nonlinear pharmacokinetics of oral quinidine and verapamil in healthy subjects: a clinical microdosing study. | 2011 Aug | 2 |
232 | 21721007 | Poor oral bioavailability of a promising anticancer agent andrographolide is due to extensive metabolism and efflux by P-glycoprotein. | 2011 Nov | 2 |
233 | 21733412 | Exposure of LS-180 cells to drugs of diverse physicochemical and therapeutic properties up-regulates P-glycoprotein expression and activity. | 2011 | 1 |
234 | 21757611 | Enhancement of oral bioavailability of 20(S)-ginsenoside Rh2 through improved understanding of its absorption and efflux mechanisms. | 2011 Oct | 2 |
235 | 21763326 | Expressions of multidrug resistance protein 1 and multidrug resistance-associated protein 1 in lung dendritic cells. | 2011 Aug 15 | 1 |
236 | 21804948 | Gemcitabine Cytotoxicity: Interaction of Efflux and Deamination. | 2011 Feb 2 | 1 |
237 | 21903258 | Synergistic effect of folate-mediated targeting and verapamil-mediated P-gp inhibition with paclitaxel -polymer micelles to overcome multi-drug resistance. | 2011 Dec | 3 |
238 | 19631272 | Xenopus laevis oocytes expressing human P-glycoprotein: probing trans- and cis-inhibitory effects on [3H]vinblastine and [3H]digoxin efflux. | 2010 Jan | 2 |
239 | 19726755 | Modulation of a Schistosoma mansoni multidrug transporter by the antischistosomal drug praziquantel. | 2010 Jan | 1 |
240 | 19914261 | Interaction of angiotensin II type 1 receptor blockers with P-gp substrates in Caco-2 cells and hMDR1-expressing membranes. | 2010 Jan 2 | 2 |
241 | 19944135 | L-type calcium channel blockers reverse docetaxel and vincristine-induced multidrug resistance independent of ABCB1 expression in human lung cancer cell lines. | 2010 Feb 15 | 2 |
242 | 19947891 | Clinical pharmacokinetics of fexofenadine enantiomers. | 2010 Jan | 2 |
243 | 19949935 | Immunosuppressors as multidrug resistance reversal agents. | 2010 | 2 |
244 | 20010957 | Assessment of regional differences in tariquidar-induced P-glycoprotein modulation at the human blood-brain barrier. | 2010 Mar | 1 |
245 | 20012601 | Pharmacokinetic interaction between oral lovastatin and verapamil in healthy subjects: role of P-glycoprotein inhibition by lovastatin. | 2010 Mar | 2 |
246 | 20069466 | No inhibitory effect on P-glycoprotein function at blood-brain barrier by clinical dose of clarithromycin: a human PET study with [¹¹C]verapamil. | 2010 Feb | 2 |
247 | 20071452 | High-activity p-glycoprotein, multidrug resistance protein 2, and breast cancer resistance protein membrane vesicles prepared from transiently transfected human embryonic kidney 293-epstein-barr virus nuclear antigen cells. | 2010 Apr | 1 |
248 | 20121715 | Induction of apoptosis by A3 adenosine receptor agonist N-(3-iodobenzyl)-adenosine-5'-N-methylcarboxamide in human leukaemia cells: a possible involvement of intracellular mechanism. | 2010 Jun | 2 |
249 | 20135207 | Model analysis of the concentration-dependent permeability of P-gp substrates. | 2010 Mar | 4 |
250 | 20336065 | Regional P-glycoprotein activity and inhibition at the human blood-brain barrier as imaged by positron emission tomography. | 2010 May | 1 |